Stay updated on Pembrolizumab vs Placebo in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Placebo in NSCLC Clinical Trial page.

Latest updates to the Pembrolizumab vs Placebo in NSCLC Clinical Trial page
- Check2 days agoChange DetectedThe site footer revision identifier changed from v3.7.2 to v3.8.0. The study record history remains unchanged.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedAn NIH-wide notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears, and the site revision changes from v3.7.1 to v3.7.2.SummaryDifference0.5%

- Check30 days agoChange DetectedThe site footer now identifies the software revision as v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check51 days agoChange DetectedThe study record history shows a new revision tag, v3.7.0, replacing the previous v3.6.6, indicating an updated revision entry for the record rather than a substantive change to study content.SummaryDifference0.1%

- Check65 days agoChange DetectedA new revision entry, v3.6.6, was added to the study history, replacing the previous v3.6.5. This indicates an updated version of the study record.SummaryDifference0.1%

- Check86 days agoChange DetectedThe record history now lists Revision: v3.6.5 as the latest version, replacing the previous v3.6.4. This reflects a new update published to the study record.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab vs Placebo in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Placebo in NSCLC Clinical Trial page.